Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novartis AG Common Stock (NY: NVS )

108.02 -1.60 (-1.46%)
Official Closing Price Updated: 7:00 PM EST, Feb 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novartis AG Common Stock

< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
43 44 Next >
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces... 
Via Benzinga
PixelMEDIA and Docmation Continue Focus on Ecommerce with GearsCRM
GearsCRM joins Pixel and Docmation to build a combined organization for delivery of a complete ecommerce solution on Salesforce. 
Via PR Leap
How To Relieve Stress - New Book, Invisible Stress By Award-Winning Author Sylvia Lafair: Kindle Version to Be Available at No Charge November 3-5, 2021
November 01, 2021 -- Sylvia Lafair is the founder of Creative Energy Options (CEOinc), a global business consulting firm and the world's leading authority in Pattern Breakthrough Leadership... 
Via 24-7 Press Release
Topics Lawsuit
Exposures Financial Legal
Earnings Scheduled For October 26, 2021
Companies Reporting Before The Bell • Veoneer (NYSE:VNE) is likely to report quarterly loss at $0.83 per share on revenue of $408.69 million. • Aarons (NYSE:AAN)... 
Via Benzinga
The Old Lady Of Threadneedle Street
US markets are up on better jobs growth reported for October today. 
Via Talk Markets
+15% CAGR & COVID-19 Impact on Difluprednate Market Can See 451 Million by 2027 Major Novartis, Ajanta Pharma, Sun Pharmaceutical, General Pharmaceuticals, Orchidia
This report presents a comprehensive overview, market shares, and growth opportunities of Difluprednate market by product type, application, key manufacturers and key regions and countries. 
Via SBWire
Exposures COVID-19
Mid-Morning Market Update: Markets Open Higher; US Economy Adds 531,000 Jobs
Following the market opening Friday, the Dow traded up 0.84% to 36,429.04 while the NASDAQ rose 0.68% to 16,049.24. The S&P also rose, gaining 0.74% to 4,714.85. The U.S. has... 
Via Benzinga
Topics Economy Stocks
Exposures Economy US Equities
Why Did Deciphera Stock Plunged 70% Today?
Deciphera Pharmaceuticals Inc (NASDAQ: DCPH) stock plunged to a 52-week after announcing disappointing results from the INTRIGUE Phase 3 study of Qinlock in... 
Via Benzinga
Biopharmaceuticals Market Is Set to Experience a Revolutionary Growth in Future
Edison, NJ -- (SBWIRE) -- 11/05/2021 -- HTF Market Intelligence added research publication document on Global Biopharmaceuticals Market breaking major business segments and highlighting wider level... 
Via SBWire
Topics Supply Chain
Exposures Supply Chain
64 Stocks Moving In Friday's Mid-Day Session
Gainers Mainz Biomed B.V. (NASDAQ: MYNZ) shares climbed 198.4% to $14.92. Mainz Biomed priced its initial public offering of 2 million ordinary shares at $5, the middle of the... 
Via Benzinga
Novartis' Iptacopan Meets Primary Endpoint Goal In Rare Kidney Disease Trial
Novartis AG (NYSE: NVS) has announced Phase 2 trial data of iptacopan, a selective factor B inhibitor, in patients with C3 glomerulopathy (C3G). In C3G, an overly-active... 
Via Benzinga
Specialty Pharmaceutical Market to Witness Massive Growth by 2028 : Pfizer, Roche, Amgen, AbbVie
Stay up-to-date with Specialty Pharmaceutical Market research offered by HTF MI. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
Exposures COVID-19
Therapeutic Radiopharmaceuticals Market May Set Epic Growth Story : Dongcheng, Q BioMed, Lantheus
Stay up-to-date with Therapeutic Radiopharmaceuticals Market research offered by HTF MI. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
Topics Supply Chain
Exposures Supply Chain
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &... 
Via Benzinga
Exposures COVID-19
Novartis To Offload Its Stake Back To Roche For $20.7B
Novartis AG (NYSE: NVS), a shareholder in Roche Holdings AG (OTC: RHHBY) for more than 20 years, would sell its entire stake, which is nearly one-third voting... 
Via Benzinga
Energize – A First-of-Its-Kind Program to Increase Access to Renewable Energy for Pharmaceutical Suppliers
SOURCE: Novartis 
Via 3BL Media
Topics Emissions Supply Chain
Exposures Supply Chain
Novartis Inks $1.3B Protein Degradation Deal With UK's Dunad
The U.K.-based Dunad Therapeutics has entered a strategic collaboration and license agreement with Novartis AG (NYSE: NVS) to generate orally... 
Via Benzinga
FDA Approves Novartis' Scemblix In Two Chronic Myeloid Leukemia Settings
The FDA has approved Novartis AG's (NYSE: NVS) Scemblix (asciminib) for chronic myeloid leukemia (CML) in two distinct indications. The FDA granted... 
Via Benzinga
Exposures Product Safety
Tuesday Market Coverage
Thermo Electron fell on the publication of its social responsibility report today. 
Via Talk Markets
Novartis (NVS) Q3 2021 Earnings Call Transcript
NVS earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Skin Cancer Therapeutics Market to Witness Massive Growth by 2028 : Bristol Myers Squibb, Eli Lilly, Roche
Stay up-to-date with Skin Cancer Therapeutics Market research offered by HTF MI. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
Exposures COVID-19
Wazoku Continues Global Expansion After Strengthening Latin American Presence
The addition of the Channge crowd plus in-market team meets the needs of Wazoku's global clients and adds greater diversity to the existing InnoCentive crowd 
Via Newswire.com
Topics Stocks
Exposures US Equities
Novartis Boosts Guidance For These Key Drugs After Their Bang-Up Quarter
Novartis stock inched higher Tuesday after the company reported a mixed third quarter, but increased guidance for two drugs. 
Via Investor's Business Daily
Novartis: Q3 Earnings Insights
Novartis (NYSE:NVS) reported its Q3 earnings results on Tuesday, October 26, 2021 at 08:00 AM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
The Daily Biotech Pulse: Moderna Gains On Vaccine News, Novartis Reports Q3 Beat, Adcom Reviews Authorization Of Pfizer-BioNTech's Vaccine For Children
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Anaptys Sells Royalties Due On Cancer Drug Jemperli To Sagard For $250M... 
Via Benzinga
Novartis Mulls Strategic Options For Sandoz, Reaffirms FY21 Outlook
Novartis AG (NYSE: NVS) reported that its Q3 net income climbed 43% to $2.76 billion. EPS reached $1.23, up 45% Y/Y. Earnings: The Company posted a core EPS of $1.71,... 
Via Benzinga
Cyber Currency
Canadian stocks are particularly buoyant and not just in energy which is a riser today because the loony is up against the buck. 
Via Talk Markets
A Preview Of Novartis's Earnings
Novartis (NYSE:NVS) is set to give its latest quarterly earnings report on Tuesday, 2021-10-26. Here's what investors need to know before the announcement. Analysts estimate that... 
Via Benzinga
Price To Earnings Ratio Insights For Novartis
In the current market session, Novartis Inc. (NYSE:NVS) is trading at $84.51, after a 0.19% decrease. However, over the past month, the stock increased by 1.91%, and... 
Via Benzinga
Global Pasireotide Market Market Overview and Forecast Report 2021:Novartis, ,
QY Research has made a brilliant attempt to elaborately and meticulously analyze the global Pasireotide market in its latest report. All of the market forecasts presented in the report are authentic... 
Via SBWire
Topics Initial Public Offering
Exposures Securities Market
< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
43 44 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.